Literature DB >> 24421824

Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec.

Sylvain Bernard1, Louis Valiquette2, Philippe De Wals3, Vincent Nault4, Corentin Babakissa5, Claude Cyr5, Thérèse Côté Boileau5, Arnaud Gagneur1.   

Abstract

BACKGROUND: Since July 2010, the National Advisory Committee on Immunization of Canada has recommended rotavirus vaccination for all healthy infants. However, before implementing this vaccine in routine health programs, Canadian provinces need to establish current epidemiological data on rotavirus-associated acute gastroenteritis (AGE).
METHODS: A retrospective cohort study of children <5 years of age with AGE from 2002 to 2008 was performed in Eastern Townships, Quebec (population in 2006: 298,780). Data were collected on visits to outpatient clinics, emergency department (ED) visits, hospitalizations (standard and short-stay units) and nosocomial AGE. The winter residual estimation and Brandt methods were used to estimate the proportion of AGE attributable to rotaviruses.
RESULTS: During the six-year study period, a total of 1435 hospitalizations, 3631 ED visits and 6220 ambulatory care visits were attributed to AGE. The specific rotavirus burden was estimated to be 449 to 666 for hospitalizations, 1050 to 1361 for ED visits and 1633 to 1687 for outpatient visits. The epidemic curve showed a periodicity with higher incidence in March and April. Short-stay unit hospitalizations represented 58% of all hospitalizations. The annual incidence rate of rotaviruses was estimated to be 50 to 74 per 10,000 children for hospitalizations, 117 to 152 per 10,000 children for ED visits and 182 to 188 per 10,000 children for outpatient visits.
CONCLUSION: Most available retrospective studies probably underestimate rotavirus-associated hospitalizations because they do not take into account short-stay unit hospitalizations. Furthermore, these data on emergency and outpatient visits provide an exhaustive appraisal of the rotavirus burden, which serves as crucial information for the evaluation of immunization programs.

Entities:  

Keywords:  Burden of disease; Children; Gastroenteritis; Health system; Rotavirus

Year:  2013        PMID: 24421824      PMCID: PMC3852450          DOI: 10.1155/2013/919124

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  24 in total

1.  Modeling seasonal variation in rotavirus hospitalizations for use in evaluating the effect of rotavirus vaccine.

Authors:  Takanori Sato; Toyoko Nakagomi; Mohammadreza Naghipour; Osamu Nakagomi
Journal:  J Med Virol       Date:  2010-08       Impact factor: 2.327

2.  Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus.

Authors:  S Jin; P E Kilgore; R C Holman; M J Clarke; E J Gangarosa; R I Glass
Journal:  Pediatr Infect Dis J       Date:  1996-05       Impact factor: 2.129

3.  Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization.

Authors:  E L Ford-Jones; E Wang; M Petric; P Corey; R Moineddin; M Fearon
Journal:  Arch Pediatr Adolesc Med       Date:  2000-06

4.  Rotavirus as a cause of diarrheal morbidity and mortality in the United States.

Authors:  M S Ho; R I Glass; P F Pinsky; L J Anderson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

5.  Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children.

Authors:  Evan J Anderson; Angela Rupp; Stanford T Shulman; Deli Wang; Xiaotian Zheng; Gary A Noskin
Journal:  Pediatrics       Date:  2011-01-24       Impact factor: 7.124

6.  Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003.

Authors:  Thea Kølsen Fischer; Cécile Viboud; Umesh Parashar; Mark Malek; Claudia Steiner; Roger Glass; Lone Simonsen
Journal:  J Infect Dis       Date:  2007-03-06       Impact factor: 5.226

7.  Burden of rotavirus disease among children visiting pediatric emergency departments in Cincinnati, Ohio, and Oakland, California, in 1999-2000.

Authors:  Eileen L Yee; Mary Allen Staat; Parvin Azimi; David I Bernstein; Richard L Ward; Charles Schubert; David O Matson; Reina M Turcios-Ruiz; Umesh Parashar; Marc-Alain Widdowson; Roger I Glass
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

8.  Pediatric viral gastroenteritis during eight years of study.

Authors:  C D Brandt; H W Kim; W J Rodriguez; J O Arrobio; B C Jeffries; E P Stallings; C Lewis; A J Miles; R M Chanock; A Z Kapikian; R H Parrott
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

9.  Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.

Authors:  Anthony R Flores; Peter G Szilagyi; Peggy Auinger; Susan G Fisher
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  3 in total

1.  Recommendations for the use of rotavirus vaccines in infants.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2017-06-30       Impact factor: 2.253

2.  Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006-2010.

Authors:  V K Morton; M K Thomas; S A McEwen
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

3.  Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.

Authors:  Virginie Gosselin; Mélissa Généreux; Arnaud Gagneur; Geneviève Petit
Journal:  Hum Vaccin Immunother       Date:  2016-07-01       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.